Pharmacokinetics and skin-tissue penetration of daptomycin in rats

Pharmacokinetics and skin-tissue penetration of daptomycin in rats

Kazuaki Matsumoto,1 Masashi Kitaoka,1 Yuko Kuroda,1 Kazuro Ikawa,2 Norifumi Morikawa,2 Junichi Sasaki,3 Osamu Iketani,4 Satoshi Iwata,4 Tetsuya Horino,5 Seiji Hori,5 Junko Kizu1 1Division of Practical Pharmacy, Keio University Faculty of Pharmacy, Tokyo, 2Department of Clinical Pharmacotherapy, Hiro...

Full description

Bibliographic Details
Main Authors:	Matsumoto K, Kitaoka M, Kuroda Y, Ikawa K, Morikawa N, Sasaki J, Iketani O, Iwata S, Horino T, Hori S, Kizu J
Format:	Article
Language:	English
Published:	Dove Medical Press 2015-05-01
Series:	Clinical Pharmacology: Advances and Applications
Online Access:	http://www.dovepress.com/pharmacokinetics-and-skin-tissue-penetration-of-daptomycin-in-rats-peer-reviewed-article-CPAA

Similar Items

Comparison of the pharmacokinetic properties of vancomycin, linezolid, tigecyclin, and daptomycin
by: Estes Kerry S, et al.
Published: (2010-11-01)

Complicated skin and soft tissue infections: literature review of evidence for and experience with daptomycin
by: White B, et al.
Published: (2011-05-01)

Bone penetration of daptomycin in diabetic patients with bacterial foot infections
by: Antoine Grillon, et al.
Published: (2019-08-01)

The Efficacy and Safety of High-dose Daptomycin in the Treatment of Complicated Skin and Soft Tissue Infections in Asians
by: Xiao-meng Dong, et al.
Published: (2020-06-01)

Daptomycin Population Pharmacokinetics in Patients Affected by Severe Gram-Positive Infections: An Update
by: Giuseppe Balice, et al.
Published: (2022-07-01)

Population Pharmacokinetic/Pharmacodynamic Modelling of Daptomycin for Schedule Optimization in Patients with Renal Impairment
by: Teresa García-Martínez, et al.
Published: (2022-10-01)

Pharmacokinetic/pharmacodynamic analysis of teicoplanin in patients with MRSA infections
by: Matsumoto K, et al.
Published: (2016-03-01)

Physiologically based pharmacokinetic modeling of daptomycin dose optimization in pediatric patients with renal impairment
by: Lingling Ye, et al.
Published: (2022-08-01)

Treatment of complicated skin and soft-tissue infections caused by resistant bacteria: value of linezolid, tigecycline, daptomycin and vancomycin
by: Eckmann Christian, et al.
Published: (2010-11-01)

Daptomycin Pharmacokinetics in Blood and Wound Fluid in Critical Ill Patients with Left Ventricle Assist Devices
by: Stefanie Calov, et al.
Published: (2023-05-01)

Pharmacokinetics and outcome of tazobactam/piperacillin in Japanese patients undergoing low-flow continuous renal replacement therapy: dosage considerations
by: Kohama H, et al.
Published: (2017-02-01)

Genomic and Long-Term Transcriptomic Imprints Related to the Daptomycin Mechanism of Action Occurring in Daptomycin- and Methicillin-Resistant Staphylococcus aureus Under Daptomycin Exposure
by: Viviana Cafiso, et al.
Published: (2020-08-01)

Defining the Active Fraction of Daptomycin against Methicillin-Resistant Staphylococcus aureus (MRSA) Using a Pharmacokinetic and Pharmacodynamic Approach.
by: Samira M Garonzik, et al.
Published: (2016-01-01)

Daptomycin in the treatment of infective endocarditis
by: Popov D.A.
Published: (2018-02-01)

Daptomycin-induced eosinophilic pneumonia
by: Sandrine Roux, et al.
Published: (2015-08-01)

Fitness Cost of Daptomycin-Resistant Staphylococcus aureus Obtained from in Vitro Daptomycin Selection Pressure
by: Shuguang Li, et al.
Published: (2017-11-01)

Optimization of nebulized delivery of linezolid, daptomycin, and vancomycin aerosol
by: Zarogoulidis P, et al.
Published: (2014-08-01)

Optical Studies of Nanodiamond-Tissue Interaction: Skin Penetration and Localization
by: Elena Perevedentseva, et al.
Published: (2019-11-01)

Dalbavancin, Vancomycin and Daptomycin Alone and in Combination with Cefazolin against Resistant Phenotypes of <i>Staphylococcus aureus</i> in a Pharmacokinetic/Pharmacodynamic Model
by: Jacinda C. Abdul-Mutakabbir, et al.
Published: (2020-10-01)

The interplay between daptomycin and the immune system
by: Theodoros eKelesidis
Published: (2014-02-01)

Intravitreal Daptomycin for Recalcitrant Postoperative Endophthalmitis
by: Jennifer M. Sim, et al.
Published: (2016-02-01)

Daptomycin-induced acute eosinophilic pneumonia
by: Preeya Goyal, et al.
Published: (2016-01-01)

New Mutations in cls Lead to Daptomycin Resistance in a Clinical Vancomycin- and Daptomycin-Resistant Enterococcus faecium Strain
by: Weiwei Li, et al.
Published: (2022-06-01)

Population pharmacokinetics and cerebrospinal fluid penetration of fluconazole in adults with cryptococcal meningitis
by: Stott, K, et al.
Published: (2018)

Breakthrough daptomycin-, linezolid-, vancomycin-resistant Enterococcus faecium bacteremia during protracted daptomycin therapy: A case report
by: Nathan B. Pincus, et al.
Published: (2022-01-01)

The Potential Role of Sulbactam and Cephalosporins Plus Daptomycin Against Daptomycin-Nonsusceptible VISA and H-VISA Isolates: An In Vitro Study
by: Chih-Cheng Lai, et al.
Published: (2019-10-01)

High-dose daptomycin and fosfomycin treatment of a patient with endocarditis caused by daptomycin-nonsusceptible <it>Staphylococcus aureus</it>: Case report
by: Hsiao Chen-Yuan, et al.
Published: (2011-05-01)

Skin deposition and penetration of trichlorocarbanilide/
by: 496679 Black, J.G., et al.

Economic burden of inpatient and outpatient antibiotic treatment for methicillin-resistant Staphylococcus aureus complicated skin and soft-tissue infections: a comparison of linezolid, vancomycin, and daptomycin
by: Stephens JM, et al.
Published: (2013-09-01)

Factors Associated with Daptomycin-Induced Eosinophilic Pneumonia
by: Kazuhiro Ishikawa, et al.
Published: (2022-02-01)

Daptomycin Induced Rhabdomyolysis and Subsequent Compartment Syndrome:
by: Katherine Esser
Published: (2023-05-01)

Daptomycin Associated Rhabdomyolysis with Concurrent Use of Atorvastatin
by: Abdulaziz Aldhafeeri
Published: (2023-05-01)

Daptomycin for highly resistant Enterococcus faecium infection
by: Christiane Rosin, et al.
Published: (2012-06-01)

Rheological Characterization of Streptomyces roseosporus for the Production of Daptomycin
by: I. Chakravarty, et al.
Published: (2017-10-01)

Effectivity of Daptomycin therapy in patients with febrile neutropenia
by: M. Meric Koc, et al.
Published: (2014-04-01)

Daptomycin Therapy for Osteomyelitis: A Retrospective Study
by: Gallagher Jason C, et al.
Published: (2012-06-01)

Daptomycin-Vancomycin–Resistant Native Valve Endocarditis
by: Khandakar Hussain MD, et al.
Published: (2016-09-01)

The combination of daptomycin with β-lactam antibiotics is more effective than daptomycin alone for vancomycin-resistant Enterococcus faecium bloodstream infection
by: Yu-Chung Chuang, et al.
Published: (2022-12-01)

Phage-Antibiotic Cocktail Rescues Daptomycin and Phage Susceptibility against Daptomycin-Nonsusceptible Enterococcus faecium in a Simulated Endocardial Vegetation Ex Vivo Model
by: Ashlan J. Kunz Coyne, et al.
Published: (2023-08-01)

Varied Contribution of Phospholipid Shedding From Membrane to Daptomycin Tolerance in Staphylococcus aureus
by: Tianwei Shen, et al.
Published: (2021-06-01)